BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34843112)

  • 1. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.
    Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM
    Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation.
    Henricksen EJ; Moayedi Y; Purewal S; Twiggs JV; Waddell K; Luikart H; Han J; Feng K; Wayda B; Lee R; Shudo Y; Jimenez S; Khush KK; Teuteberg JJ
    Clin Transplant; 2023 Mar; 37(3):e14699. PubMed ID: 35559582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD
    Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.
    Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA
    Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.
    Rodgers N; Gerding B; Cusi V; Vaida F; Tada Y; Morris GP; Adler ED; Stehlik J; Kim PJ
    Clin Transplant; 2023 Jun; 37(6):e14984. PubMed ID: 37036133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
    Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
    J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.
    Khush K; Hall S; Kao A; Raval N; Dhingra R; Shah P; Bellumkonda L; Ravichandran A; Van Bakel A; Uriel N; Patel S; Pinney S; DePasquale E; Baran DA; Pinney K; Oreschak K; Kobulnik J; Shen L; Teuteberg J
    J Heart Lung Transplant; 2024 May; ():. PubMed ID: 38759766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The End of Endomyocardial Biopsy?: A Practical Guide for Noninvasive Heart Transplant Rejection Surveillance.
    Holzhauser L; DeFilippis EM; Nikolova A; Byku M; Contreras JP; De Marco T; Hall S; Khush KK; Vest AR
    JACC Heart Fail; 2023 Mar; 11(3):263-276. PubMed ID: 36682960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
    Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience.
    Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B
    Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparing the Prod: Providing an Alternative to Endomyocardial Biopsies With Noninvasive Surveillance After Heart Transplantation During COVID-19.
    Amadio JM; Rodenas-Alesina E; Superina S; Kozuszko S; Tsang K; Simard A; Aleksova N; Kobulnik J; Fan CS; Wijeysundera HC; Ross HJ; McDonald MA; Duero Posada JG; Moayedi Y
    CJC Open; 2022 May; 4(5):479-487. PubMed ID: 35187463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.